<DOC>
	<DOCNO>NCT02031822</DOCNO>
	<brief_summary>Headache one common reason patient access healthcare . Greater occipital nerve ( GON ) block local anesthetic steroid describe management primary headache refractory conventional treatment . Two ultrasound ( US ) -guided technique great occipital nerve ( GON ) block describe management refractory headache syndrome : proximal technique perform level second cervical vertebra distal technique perform level superior nuchal line . Our airm compare accuracy , efficacy safety two technique patient refractory headache .</brief_summary>
	<brief_title>Two US-guided Techniques Greater Occipital Nerve Blocks</brief_title>
	<detailed_description>We conduct double-blinded , randomize control trial compare accuracy , efficacy safety two technique patient refractory headache syndrome . Following REB approval , 40 patient moderate severe refractory headache ( intensity score &gt; 4/10 ) randomize `` proximal '' `` distal '' group 1:1 allocation . Each patient receive injection 2ml 0.5 % bupivacaine 40mg methylprednisolone . The null hypothesis difference intensity score headache one month intervention . Outcomes related efficacy ( numbness immediately injection , reduction episode severe headache , sleep quality ) , performance ( time take discomfort procedure ) , safety ( incidence hematoma , intravascular injection ) measure one month .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<criteria>1 . Features suggestive occipital neuralgia : pain begin upper neck back head radiation forward toward eye ache burn character . 2 . Diagnosis refractory primary headache , type 3 . Baseline NRS headache score &gt; 4 refractory conventional oral analgesic therapy ( antiinflammatory drug , migraine prophylaxis treatment drug , opioids ) . 1 . Ongoing litigation issue relate patient 's pain 2 . Pregnancy 3 . Allergy steroids local anesthetic 4 . Multiple serious comorbidities 5 . Age &lt; 18 age â‰¥ 80 year 6 . GON injection within last 3 month time entry trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Primary Headache</keyword>
	<keyword>Greater Occipital Nerve</keyword>
	<keyword>Ultrasound</keyword>
	<keyword>Chronic Pain</keyword>
	<keyword>Cervicogenic</keyword>
	<keyword>Occipital Neuralgia</keyword>
	<keyword>Migraine</keyword>
	<keyword>Tension type headache</keyword>
	<keyword>Cluster headache</keyword>
</DOC>